GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » ROC (Joel Greenblatt) %

Curatis Holding AG (CHIX:CURNZ) ROC (Joel Greenblatt) % : -1,621,900.00% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Curatis Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -1,621,900.00%.

The historical rank and industry rank for Curatis Holding AG's ROC (Joel Greenblatt) % or its related term are showing as below:

CHIX:CURNz' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -608988   Med: -453210   Max: -398930
Current: -608988

During the past 3 years, Curatis Holding AG's highest ROC (Joel Greenblatt) % was -398930.00%. The lowest was -608988.00%. And the median was -453210.00%.

CHIX:CURNz's ROC (Joel Greenblatt) % is ranked worse than
100% of 1059 companies
in the Drug Manufacturers industry
Industry Median: 8.07 vs CHIX:CURNz: -608988.00

Curatis Holding AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Curatis Holding AG ROC (Joel Greenblatt) % Historical Data

The historical data trend for Curatis Holding AG's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG ROC (Joel Greenblatt) % Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
- -398,930.00 -507,490.00

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial - -18,800.00 -822,042.11 -52,300.00 -1,621,900.00

Competitive Comparison of Curatis Holding AG's ROC (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curatis Holding AG's ROC (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's ROC (Joel Greenblatt) % falls into.



Curatis Holding AG ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.103) - (0.105 + 0 + 0.482)
=-0.484

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.041 + 0 + 0.258)
=-0.299

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Curatis Holding AG for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-97.314/( ( (0.006 + max(-0.484, 0)) + (0 + max(-0.299, 0)) )/ 1 )
=-97.314/( ( 0.006 + 0 )/ 1 )
=-97.314/0.006
=-1,621,900.00 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curatis Holding AG  (CHIX:CURNz) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Curatis Holding AG ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG (CHIX:CURNZ) Business Description

Traded in Other Exchanges
Address
Hochbergerstrasse 60C, Technologiepark Basel, Basel, CHE, 4057
Kinarus Therapeutics Holding AG In Liquidation Formerly Kinarus Therapeutics Holding AG is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. The company's therapeutic drug candidate, KIN001, consists of a clinical-stage p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, combined with a marketed drug, together enabling an oral, long-term effective treatment for patients suffering from diseases with serious impact on quality of life.

Curatis Holding AG (CHIX:CURNZ) Headlines

No Headlines